Inflation Reduction Act: Resources and Advocacy

The Inflation Reduction Act, signed in August 2022, includes provisions that impact community pharmacy.

Please see below for some resources on the Inflation Reduction Act.

NCPA Comments

Studies

  • Avalere study showing the Medicare Drug Price Negotiation program’s significant impact on beneficiaries, independent pharmacies (March 2025)

  • 3 Axis Advisors study showing financial impact of the Medicare Drug Price Negotiation program on independent pharmacies (January 2025)

NCPA Resources

  • NCPA member summary on CMS’ CY 2026 Medicare Part D/MA final rule (April 2025)

  • NCPA Medicare Drug Price Negotiation Program talking points (November 2024)

  • NCPA member summary on CMS’ guidance on the Medicare Drug Price Negotiation Program (October 2024)

  • NCPA member summary on CMS’ guidance on the Medicare Prescription Payment Plan (MPPP)/”co-pay smoothing” (July 2024)

Centers for Medicare and Medicaid Services (CMS) Resources